Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36

Transforming growth factor-beta-1 (TGF-beta 1) is secreted by cells in. a l atent form (L-TGF-beta 1) noncovalently bound to a latency-associated pepti de. Activated alveolar macrophages obtained from rat lungs after bleomycin- induced pulmonary injury released increased amounts of active TGF-beta 1 as well as plasmin, a protease, and thrombospondin-1 (TSF-1), a trimeric glyc oprotein. Previously we had demonstrated that plasmin was critical to the a ctivation of L-TGF-beta 1. In the present study we demonstrated that TSP-1 is also important for the activation of L-TGF-beta 1 because the activation can be inhibited by anti-TSP-1 monoclonal antibody. Proteins obtained from alveolar macrophage cell lysates immunoprecipitated with antibodies specif ic for TSF-1 were identified on immunoblots as LAP and TGF-beta 1, indicati ng that TSP-1/L-TGF-beta 1 complexes are present on alveolar macrophages, H owever, in the presence of plasmin both latency-associated peptide and TGF- beta 1 were decreased in the same cell lysates, indicating that L-TGF-beta 1 associated with TSP-1 is released by plasmin, Using immunofluorescence an d antibodies to TGF-beta 1 and CD36, a receptor for TSP-1, there was coloca lization of TGF-beta 1 with CD36, Because TSP-1 but not TGF-beta 1 is a nat ural ligand for CD36, these findings suggest that the L-TGF-beta 1 in a com plex with TSP-1 localizes to the macrophage cell surface when TSP-1 interac ts with its receptor, CD36, Furthermore, the association of TSP-1/L-TGF-bet a 1 complex with CD36 is necessary to the activation of L-TGF-beta 1 becaus e antibodies to CD36 prevent the colocalization of TGF-beta 1 with CD36 as observed by immunofluorescence and inhibit activation of the L-TGF-beta 1 b y explanted alveolar macro-phages, These findings suggest that activation o f L-TGF-beta 1 by plasmin occurs at the cell surface of activated alveolar macrophages and requires a TSP-1/CD36 interaction.